Skip to content

Seizure Detection and Warning System for Epilepsy Patients

A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01874600
Enrollment
239
Registered
2013-06-11
Start date
2013-07-31
Completion date
2019-12-31
Last updated
2019-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to alert caregivers that a seizure is occurring.

Interventions

DEVICEBrain Sentinel Seizure Detection Device and Warning System

The Brain Sentinel Seizure Detection Device and Warning System is designed to monitor Epilepsy patients and alerts caregivers that a GTC seizure is occurring

Sponsors

Brain Sentinel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
13 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

1. Subject has a suspected history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization. 2. Is being admitted to a hospital for routine vEEG monitoring related to seizures. 3. Male or female between the ages of 13-21. 4. If female and of childbearing potential, has a negative pregnancy urine test, and must also not be nursing. 5. Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments. 6. Subject and/or Primary Caregiver must be competent to follow all study procedures. 7. Is able to read, speak, and understand English or has a LAR that does so. 8. Subject/LAR consents to the use of vEEG files, including video/audio recordings, for purposes of this research study.

Exclusion criteria

1. Has not had a GTC seizure within the last year AND is not expected to have a reduction of anti-epileptic drugs during their hospital admission. 2. Intracranial EEG electrodes are being used. 3. The subject is allergic to adhesives or any component of the electrode patch assembly

Design outcomes

Primary

MeasureTime frameDescription
Primary outcome is accuracy of device to detect GTC seizures when compared to video EEG.less than 1 monthThe primary objective of the research is to determine the ability of the Brain Sentinel Seizure Detection System to accurately detect GTC seizures in comparison to the recognized gold standard for seizure detection, video Electroencephalography (vEEG).The primary endpoint will be the sensitivity of GTC seizure detection (defined as within 30 seconds of motor manifestation via vEEG analysis) in a hospital setting.

Secondary

MeasureTime frameDescription
Comparison of study device to self reporting of seizures using a seizure diary.Less than 1 monthThe secondary objective is to assess the operation of the Brain Sentinel Seizure Detection System when used in the subject's home and to compare the GTC seizure reporting of the device to a standard seizure diary completed by the subject/caregiver.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026